| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 01/26/2011 | EP1948616B1 2-(benzimidazol-1-yl)-acetamide biaryl derivatives and their use as inhibitors of the trpv1 receptor |
| 01/26/2011 | EP1831173B1 Tetrahydroisoquinoline compounds for treatment of cns disorders |
| 01/26/2011 | EP1633733B1 Cannabinoid derivatives, methods of making, and use thereof |
| 01/26/2011 | EP1554239B1 Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists |
| 01/26/2011 | EP1496892B1 1h-benzo(f)indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 01/26/2011 | CN101959883A 3-indazolyl-4-pyridylisothiazoles |
| 01/26/2011 | CN101959882A 咪唑羰基化合物 Imidazole-carbonyl compound |
| 01/26/2011 | CN101959879A 5-oxo-2, 3,4,5-tetrahydro-benzo[B]oxepine-4-carboxylic acid amides and 2,3-dihydro-benzo[B]oxepine-4-carboxylic acid amides for treatment and prevention of diabetes typ 1 and 2 |
| 01/26/2011 | CN101959865A Quinolines as inhibitors of farnesyl pyrophosphate synthase |
| 01/26/2011 | CN101959515A Glucokinase activators |
| 01/25/2011 | US7875728 Hydrazonopyrazole derivatives and their use as therapeutics |
| 01/25/2011 | US7875726 Thiazolidin-4-one derivatives |
| 01/25/2011 | US7875647 Heteroaryl-pyrazole derivatives as cannabinoid CB1 receptor antagonists |
| 01/25/2011 | US7875639 Such as N-[3-(2-methoxyethyl)-1,3-thiazol-2(3H)-ylidene]adamantane-1-carboxamide; neuropathic, nociceptive and/or inflammatory pain; neuroprotection |
| 01/25/2011 | US7875638 desoxyepothilone A and B; Fludelone; anticarcinogenic agents; drug resistance; water solubility for formulability; industrial scale; cytotoxic or growth inhibitory effects on CAG myeloma cells lines; ability to polymerize tubulin; minimum toxicity; isomerization of the double bonds in the ring |
| 01/25/2011 | US7875619 Hetero substituted sodium channel blockers |
| 01/25/2011 | US7875609 3-(4-chlorophenyl)-1-(3,3-diphenylpropyl)-1-(2-morpholin-4-ylethyl)urea; treatment of the cancer of the parathyroid and the digestive tract; osteoporosis, osteopaenia and Paget's disease, rheumatoid arthritis and osteoarthritis |
| 01/25/2011 | US7875607 7,8-bicycloakyl-chroman derivatives |
| 01/25/2011 | US7875606 Izoxazoline derivative and herbicide |
| 01/25/2011 | US7875600 To reducte the purinergic neurotransmission; Parkinson's disease; dyskinesias; Movement disorders; Adenosine receptors antagonists; 2-Methylamino-6-(5-methyl-2-furyl)-N-(2-pyridylmethyl)pyrimidine-4-carboxamide |
| 01/25/2011 | CA2612287C Substituted arylpyrazoles for use against parasites |
| 01/25/2011 | CA2494323C Amino benzothiazole compounds with nos inhibitory activity |
| 01/25/2011 | CA2460180C Microbiocidal n-phenyl-n-[4-(4-pyridyl)-2-pyrimidin-2-yl]-amine derivatives |
| 01/25/2011 | CA2410345C Substituted pyridine herbicides |
| 01/25/2011 | CA2404125C Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 01/20/2011 | WO2011007839A1 4-(3-butynyl)aminopyrimidine derivatives as pest control agents for agricultural and horticultural use |
| 01/20/2011 | WO2011007819A1 Pharmaceutical product containing lactam or benzene sulfonamide compound |
| 01/20/2011 | WO2011006960A1 Spiro amino compounds suitable for the treatment of inter alia sleep disorders and drug addiction |
| 01/20/2011 | WO2011006935A2 Tetrazole derivatives |
| 01/20/2011 | WO2011006803A1 3-0x0-2, 3, -dihydro-lh-isoindole-4-carboxamides with selective parp-1 inhibition |
| 01/20/2011 | WO2011006794A1 3-oxo-2, 3-dihydro-lh-isoindole-4-carboxamides as parp inhibitors |
| 01/20/2011 | WO2011006604A1 Substituted aminothiazoles and use thereof as fungicides |
| 01/20/2011 | WO2011006567A1 Aminopyridine derivatives for treating tumors and inflammatory diseases |
| 01/20/2011 | US20110015240 Thiazole derivative and use thereof as vap-1 inhibitor |
| 01/20/2011 | US20110015238 Blood flow promoters for cauda equina tissues |
| 01/20/2011 | US20110015236 Fungicide hydroximoyl-tetrazole derivatives |
| 01/20/2011 | US20110015225 Heterocyclic compound |
| 01/20/2011 | US20110015203 Viral Polymerase Inhibitors |
| 01/20/2011 | US20110015201 Hedgehog pathway antagonists and methods of use |
| 01/20/2011 | US20110015192 Sirtuin modulating compounds |
| 01/20/2011 | US20110015181 Alkylaminopyridine derivative |
| 01/20/2011 | US20110015178 Amido-Thiophene Compounds and Their Use |
| 01/20/2011 | US20110015175 Bicyclic Compounds for the Reduction of Beta-Amyloid Production |
| 01/20/2011 | US20110015171 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 01/20/2011 | US20110015170 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 01/20/2011 | US20110015157 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 01/20/2011 | US20110015156 Heterocyclic compounds for the treatment of neurological and psychological disorders |
| 01/20/2011 | US20110014599 Novel Fluorescent Dyes and Uses Thereof |
| 01/20/2011 | US20110014250 Inhibitors of 15-hydroxyprostaglandin dehydrogenase for stimulating pigmentation of the skin or skin appendages |
| 01/20/2011 | US20110014121 Modulators of cxcr7 |
| 01/20/2011 | US20110012075 Infrared absorptive compound, and fine particle containing the compound |
| 01/20/2011 | CA2768329A1 Spiro amino compounds suitable for the treatment of inter alia sleep disorders and drug addiction |
| 01/20/2011 | CA2768169A1 Aminopyridine derivatives for the treatment of tumors and inflammatory diseases |
| 01/20/2011 | CA2767887A1 Benzimidazole analogues for the treatment or prevention of flavivirus infections |
| 01/20/2011 | CA2766874A1 Tetrazole derivatives |
| 01/20/2011 | CA2765661A1 4-(3-butynyl)aminopyrimidine derivatives as pest control agents for agricultural and horticultural use |
| 01/19/2011 | EP2275421A1 Spiro amino compounds suitable for the treatment of inter alia sleep disorders and drug addiction |
| 01/19/2011 | EP2275102A1 N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 01/19/2011 | EP2274306A1 Novel compounds as cannabinoid receptor ligands |
| 01/19/2011 | EP2274299A1 Heteroaryl-substituted dicyanopyridines and use thereof for treatment of cardiovascular diseases |
| 01/19/2011 | EP2274297A1 Pyrrolidinone glucokinase activators |
| 01/19/2011 | EP2274296A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists |
| 01/19/2011 | EP2274295A1 3, 4 - substituted piperidine derivatives as renin inhibitors |
| 01/19/2011 | EP2274287A1 Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 |
| 01/19/2011 | EP2274282A1 Compounds for use in stabilizing p53 mutants |
| 01/19/2011 | EP2273992A1 Quenolines and related analogs as sirtuin modulators |
| 01/19/2011 | EP2150546B1 Pyrimidine derivatives as inhibitors of phosphatidylinositol-3-kinase |
| 01/19/2011 | EP2094685B1 3-heteroaryl (amino or amido)-1- (biphenyl or phenylthiazolyl) carbonylpiperdine derivatives as orexin receptor inhibitors |
| 01/19/2011 | EP2035375B1 1,3-disubstituted 4-methyl-1h-pyrrole-2-carboxamides and their use for the manufacture of medicaments |
| 01/19/2011 | EP1432416B1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 01/19/2011 | EP1330442B1 Phthalazinone derivatives |
| 01/19/2011 | CN101952282A Thiazole derivatives used as PI 3 kinase inhibitors |
| 01/19/2011 | CN101952281A Indole and indazole derivatives having a cell-, tissue- and organ-preserving effect |
| 01/19/2011 | CN101952280A Bicyclic heterocyclic derivative |
| 01/19/2011 | CN101952275A Modulators for amyloid beta |
| 01/19/2011 | CN101952267A Cyclopropyl amine derivatives |
| 01/19/2011 | CN101952259A Benzodiazepine compound and pharmaceutical composition |
| 01/19/2011 | CN101952247A Intermediate compounds for the preparation of meso-substituted cyanine, merocyanine and oxonole dyes |
| 01/19/2011 | CN101951904A Benzothiazole and benzoxazole derivatives and methods of use |
| 01/19/2011 | CN101951771A Composition for agricultural use for controlling or preventing plant diseases caused by plant pathogens |
| 01/19/2011 | CN101948467A Thiazoleamide compound and use thereof for the preparation of anti-malignant tumor medicines |
| 01/19/2011 | CN101948466A Asymmetric heterocyclic ring substituent urea compound and preparation method and application thereof |
| 01/19/2011 | CN101948465A Method for preparing vitamin B1 intermediate |
| 01/19/2011 | CN101948462A Azaspiroalkene and azaspiroalkane compounds with nicotinic cholinergic receptor activity |
| 01/19/2011 | CN101948458A Baicalein derivatives with antitumor activity and application thereof in medicines |
| 01/19/2011 | CN101362731B Heterocyclic compounds and methods of use |
| 01/19/2011 | CN101237885B Agent for regeneration and/or protection of nerves |
| 01/19/2011 | CN101184489B Pharmaceutical composition |
| 01/19/2011 | CN101052638B 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 01/18/2011 | US7872142 Coumarin derivatives useful as TNFα inhibitors |
| 01/18/2011 | US7872139 Heteroaryl-ureas and their use as glucokinase activators |
| 01/18/2011 | US7872129 Nitrogen compounds such as (6-(3-Methylaminopropyl)-2-(2-tri-fluoromethylphenyl)pyrimidin-4-yl)-(1H -pyrazolo(3,4-b)pyridin-3-yl)-amine, use as glycogen synthase kinase-3 (GSK-3) antagonists |
| 01/18/2011 | US7872039 3-aminoindazoles |
| 01/18/2011 | US7872033 N-[(5Z)-4-butyl-2-tert-butylisothiazol-5(2H)-ylidene]-5-chloro-2-methoxybenzamide; CB2 receptors ligand; antiinflammatory, analgesic agent; autoimmune diseases; neuroprotectants |
| 01/18/2011 | US7872032 1, 3, 4-oxadiazol-2-ones as PPAR delta modulators and their use thereof |
| 01/18/2011 | US7872027 Low molecular weight Myc-max inhibitors |
| 01/18/2011 | US7871999 Substituted thiazoles and their use for producing drugs |
| 01/18/2011 | US7871773 Aza-benzazolium containing cyanine dyes |
| 01/18/2011 | CA2573219C Hepatitis c inhibitor dipeptide analogs |
| 01/18/2011 | CA2491895C Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |